(Q38793054)

6 September 2017

1 reference

title

The role of phosphate in kidney disease (English)

1 reference

6 September 2017

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27867189%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Marc G Vervloet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27867189%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Siren Sezer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27867189%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Ziad A Massy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27867189%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Lina Johansson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27867189%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Denis Fouque

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27867189%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

ERA–EDTA Working Group on Chronic Kidney Disease–Mineral and Bone Disorders and the European Renal Nutrition Working Group

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27867189%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

language of work or name

English

0 references

publication date

21 November 2016

1 reference

Nature Reviews Nephrology

6 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27867189%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27867189%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27867189%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

27-38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27867189%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrneph.2016.164

5 June 2020

exact match

0 references

cites work

Novel mechanisms in the regulation of phosphorus homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Biological variability of plasma intact and C-terminal FGF23 measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Effects of a high-protein diet on regulation of phosphorus homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Circadian variation of mineral and bone parameters in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Fibroblast growth factor 23

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Can features of phosphate toxicity appear in normophosphatemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Persistently elevated parathyroid hormone secretion and action in young women after four weeks of ingesting high phosphorus, low calcium diets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Acute Effects of Different Phosphorus Sources on Calcium and Bone Metabolism in Young Women: A Whole-Foods Approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Effects of dietary phosphate and calcium intake on fibroblast growth factor-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Gastrointestinal phosphate handling in CKD and its association with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Dietary educational interventions for management of hyperphosphatemia in hemodialysis patients: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Regression equation predicts dietary phosphorus intake from estimate of dietary protein intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Reduction of phytic acid and enhancement of bioavailable micronutrients in food grains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Prevalence of Phosphorus-Based Additives in the Australian Food Supply: A Challenge for Dietary Education?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Dietary considerations to prevent loss of bone and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

The prevalence of phosphorus-containing food additives in top-selling foods in grocery stores

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Phosphorus content of popular beverages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Use of a standard urine assay for measuring the phosphate content of beverages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Novel differential measurement of natural and added phosphorus in cooked ham with or without preservatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Contribution of food additives to sodium and phosphorus content of diets rich in processed foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

A dearth of data: the problem of phosphorus in prescription medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Medication is an additional source of phosphate intake in chronic kidney disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Joint Effect of Hypertension and Elevated Serum Phosphorus on the Risk of Mortality in National Health and Nutrition Examination Survey-III

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Phosphorus and risk of renal failure in subjects with normal renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Serum phosphate and mortality in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

The Impact of Normal Range of Serum Phosphorus on the Incidence of End-Stage Renal Disease by A Propensity Score Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Serum phosphate levels and mortality risk among people with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: redundant roles for PiT-1 and PiT-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Distinct Effects of Inorganic Phosphate on Cell Cycle and Apoptosis in Human Vascular Smooth Muscle Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Increased inorganic phosphate induces human endothelial cell apoptosis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

High phosphate directly affects endothelial function by downregulating annexin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

A new in vitro model to delay high phosphate-induced vascular calcification progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

High inorganic phosphate concentration inhibits osteoclastogenesis by modulating miR-223.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Dietary phosphorus acutely impairs endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Chronic kidney disease and premature ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Pro: cardiovascular calcifications are clinically relevant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Initial FGF23-mediated signaling occurs in the distal convoluted tubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

FGF23 induces left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Forging forward with 10 burning questions on FGF23 in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Mineral metabolites and CKD progression in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Vascular calcification in chronic kidney disease: a changing scenario.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Pathogenesis of vascular calcification in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

The "phosphorus pyramid": a visual tool for dietary phosphate management in dialysis and CKD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Dietary phosphorus restriction in predialysis chronic kidney disease: time for a cease-fire?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Use of nicotinamide to treat hyperphosphatemia in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Serum Magnesium and Sudden Death in European Hemodialysis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Effects of phosphate binders in moderate CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Serum phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Dietary and pharmacological modification of fibroblast growth factor-23 in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Results of a pilot program to improve phosphorus outcomes in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Mortality in kidney disease patients treated with phosphate binders: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Effects of sevelamer hydrochloride on mortality, lipid abnormality and arterial stiffness in hemodialyzed patients: a propensity-matched observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Use of phosphate-binding agents is associated with a lower risk of mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Circadian rhythms of blood minerals in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

The absorption of dietary phosphorus and calcium in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Hidden Sources of Phosphorus in the Typical American Diet: Does it Matter in Nephrology?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

A Long Road to Travel: Adherence to Dietary Recommendations and Adequate Dietary Phosphorus Control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Food and Drug Administration petition on food labeling: an update from the American Dietetic Association and National Kidney Foundation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Relationship of phosphorus and calcium-phosphorus product with mortality in CKD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Effects of phosphate on vascular function under normal conditions and influence of the uraemic state

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

The treatment of hyperphosphataemia in CKD: calcium-based or calcium-free phosphate binders?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.164

The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification.

31 March 2020

1 reference

12 December 2020

Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients

1 reference

12 December 2020

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

1 reference

12 December 2020

Circadian rhythm of serum phosphate, calcium and parathyroid hormone levels in hemodialysis patients

1 reference

12 December 2020

Phosphate levels--time for a rethink?

1 reference

12 December 2020

Relationship between reductions in parathyroid hormone and serum phosphorus during the management of secondary hyperparathyroidism with calcimimetics in hemodialysis patients

1 reference

12 December 2020

The parathyroid hormone circadian rhythm is truly endogenous--a general clinical research center study

1 reference

12 December 2020